PortalPublikationenPharmacological treatment of dementia and mild cognitive imp...

Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.

Standard

Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease. / Popp, Julius; Arlt, Sönke.

in: CURR OPIN PSYCHIATR, Jahrgang 24, Nr. 6, 6, 2011, S. 556-561.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Popp, J & Arlt, S 2011, 'Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.', CURR OPIN PSYCHIATR, Jg. 24, Nr. 6, 6, S. 556-561. <http://www.ncbi.nlm.nih.gov/pubmed/21934621?dopt=Citation>

APA

Popp, J., & Arlt, S. (2011). Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease. CURR OPIN PSYCHIATR, 24(6), 556-561. [6]. http://www.ncbi.nlm.nih.gov/pubmed/21934621?dopt=Citation

Vancouver

Popp J, Arlt S. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease. CURR OPIN PSYCHIATR. 2011;24(6):556-561. 6.

Bibtex

@article{d3094221be1e48aa826455b8679c5471,
title = "Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.",
abstract = "To give an overview of recent developments in pharmacological treatment options of cognitive as well as behavioural and psychological symptoms of dementia (BPSD) associated with Alzheimer's disease (AD) dementia and mild cognitive impairment due to AD (MCI-AD).",
keywords = "Humans, Cholinesterase Inhibitors/*therapeutic use, Alzheimer Disease/*complications/drug therapy, Antipsychotic Agents/*therapeutic use, Dementia/*drug therapy, Dopamine Agents/*therapeutic use, Mild Cognitive Impairment/*drug therapy, Humans, Cholinesterase Inhibitors/*therapeutic use, Alzheimer Disease/*complications/drug therapy, Antipsychotic Agents/*therapeutic use, Dementia/*drug therapy, Dopamine Agents/*therapeutic use, Mild Cognitive Impairment/*drug therapy",
author = "Julius Popp and S{\"o}nke Arlt",
year = "2011",
language = "English",
volume = "24",
pages = "556--561",
journal = "CURR OPIN PSYCHIATR",
issn = "0951-7367",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.

AU - Popp, Julius

AU - Arlt, Sönke

PY - 2011

Y1 - 2011

N2 - To give an overview of recent developments in pharmacological treatment options of cognitive as well as behavioural and psychological symptoms of dementia (BPSD) associated with Alzheimer's disease (AD) dementia and mild cognitive impairment due to AD (MCI-AD).

AB - To give an overview of recent developments in pharmacological treatment options of cognitive as well as behavioural and psychological symptoms of dementia (BPSD) associated with Alzheimer's disease (AD) dementia and mild cognitive impairment due to AD (MCI-AD).

KW - Humans

KW - Cholinesterase Inhibitors/therapeutic use

KW - Alzheimer Disease/complications/drug therapy

KW - Antipsychotic Agents/therapeutic use

KW - Dementia/drug therapy

KW - Dopamine Agents/therapeutic use

KW - Mild Cognitive Impairment/drug therapy

KW - Humans

KW - Cholinesterase Inhibitors/therapeutic use

KW - Alzheimer Disease/complications/drug therapy

KW - Antipsychotic Agents/therapeutic use

KW - Dementia/drug therapy

KW - Dopamine Agents/therapeutic use

KW - Mild Cognitive Impairment/drug therapy

M3 - SCORING: Journal article

VL - 24

SP - 556

EP - 561

JO - CURR OPIN PSYCHIATR

JF - CURR OPIN PSYCHIATR

SN - 0951-7367

IS - 6

M1 - 6

ER -